Pharma Reaserch Prod Co Ltd (214450) — Net Asset Quality Index
Pharma Reaserch Prod Co Ltd (214450) has a Net Asset Quality Index of 69.3% as of December 2025. This metric measures the proportion of total assets financed by shareholders' equity — total assets of ₩1.04 Trillion minus total liabilities of ₩320.01 Billion yields net assets of ₩723.88 Billion. A higher index indicates a stronger, lower-leverage balance sheet. Read total liabilities of Pharma Reaserch Prod Co Ltd for a breakdown of total debt and financial obligations.
Quality Index
Net Assets
Total Assets
Total Liabilities
Pharma Reaserch Prod Co Ltd Net Asset Quality Index Over Time (2015–2025)
This chart shows how Pharma Reaserch Prod Co Ltd's Net Asset Quality Index has evolved across 11 annual periods from 2015 to 2025. As of December 2025, the index stands at 69.3%, representing net assets of ₩723.88 Billion against total assets of ₩1.04 Trillion KRW. For live market cap and overall valuation, see Pharma Reaserch Prod Co Ltd market capitalisation.
Annual Net Asset Quality Index for Pharma Reaserch Prod Co Ltd (2015–2025)
The table below presents the year-by-year Net Asset Quality Index for Pharma Reaserch Prod Co Ltd from 2015 to 2025, covering 11 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. Check 214450 strategic assets to equity ratio to assess the company's strategic physical and investment asset allocation.
| Year | Quality Index | Net Assets (KRW) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2025 | 69.3% | ₩723.88 Billion | ₩1.04 Trillion | ₩320.01 Billion | ▲ +2.8 pp |
| 2024 | 66.5% | ₩569.44 Billion | ₩855.70 Billion | ₩286.26 Billion | ▼ -19.8 pp |
| 2023 | 86.3% | ₩462.19 Billion | ₩535.28 Billion | ₩73.09 Billion | ▲ +14.5 pp |
| 2022 | 71.9% | ₩343.50 Billion | ₩478.06 Billion | ₩134.55 Billion | ▲ +0.4 pp |
| 2021 | 71.4% | ₩305.44 Billion | ₩427.65 Billion | ₩122.20 Billion | ▼ -5.3 pp |
| 2020 | 76.7% | ₩245.42 Billion | ₩319.83 Billion | ₩74.41 Billion | ▼ -0.7 pp |
| 2019 | 77.5% | ₩209.07 Billion | ₩269.93 Billion | ₩60.85 Billion | ▲ +0.9 pp |
| 2018 | 76.5% | ₩197.62 Billion | ₩258.19 Billion | ₩60.56 Billion | ▼ -18.1 pp |
| 2017 | 94.6% | ₩178.85 Billion | ₩189.03 Billion | ₩10.18 Billion | ▼ -1.1 pp |
| 2016 | 95.7% | ₩171.64 Billion | ₩179.33 Billion | ₩7.69 Billion | ▲ +3.1 pp |
| 2015 | 92.6% | ₩156.75 Billion | ₩169.31 Billion | ₩12.56 Billion | — |